Over at In the Pipeline, Derek Lowe makes an analogy, comparing the movie business to big pharma. The similarities, he writes, are that both incur most of their costs in R&D and marketing spending and blockbusters are hard to predict. The differences are that the barrier to entry is a lot higher for distributing new drugs and movies can make money longer than patented drugs.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Direct-to-consumer genetic testing companies have offered to test families separated at the southern US border, but that raises ethical issues.

CNBC reports that confirming a positive result from 23andMe's BRCA health report can be expensive.

The New York Times reports on a project to develop a tree DNA database to uncover illegal logging.

In PLOS this week: links between gut microbiome and colorectal cancer mutations, targeted sequencing uncovers genetic susceptibilities to epilepsy in Koreans, and more.